Exane Derivatives’s Philip Morris PM Stock Holding History

Exane Derivatives’s Portfolio PM Stock Details PM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.28K	Sell	13 -10	-43%	-$1.02K	﹤0.01%	479
2022 Q1	$2.16K	Hold	23	–	–	﹤0.01%	746
2021 Q4	$2.19K	Sell	23 -5,222	-100%	-$488K	﹤0.01%	663
2021 Q3	$497K	Sell	5,245 -3,908	-43%	-$393K	0.12%	192
2021 Q2	$894K	Sell	9,153 -911	-9%	-$87.4K	0.2%	100
2021 Q1	$893K	Buy	10,064 +6,301	+167%	+$535K	0.26%	90
2020 Q4	$312K	Buy	3,763 +715	+23%	+$55.7K	0.09%	241
2020 Q3	$229K	Buy	3,048 +1,750	+135%	+$135K	0.07%	201
2020 Q2	$90.9K	Sell	1,298 -20,348	-94%	-$1.48M	0.02%	308
2020 Q1	$1.58M	Sell	21,646 -2,138	-9%	-$176K	0.44%	55
2019 Q4	$2.1M	Sell	23,784 -3,821	-14%	-$315K	0.39%	81
2019 Q3	$2.1M	Buy	27,605 +17,157	+164%	+$1.36M	0.38%	65
2019 Q2	$820K	Sell	10,448 -36,919	-78%	-$3.05M	0.14%	115
2019 Q1	$4.19M	Buy	47,367 +6,955	+17%	+$560K	0.83%	29
2018 Q4	$2.7M	Sell	40,412 -3,572	-8%	-$298K	0.48%	61
2018 Q3	$3.59M	Sell	43,984 -35,898	-45%	-$2.95M	0.67%	34
2018 Q2	$6.45M	Buy	79,882 +21,113	+36%	+$1.79M	1.08%	22
2018 Q1	$5.86M	Buy	58,769 +16,024	+37%	+$1.67M	1.17%	16
2017 Q4	$4.51M	Buy	42,745 +21,192	+98%	+$2.26M	0.78%	20
2017 Q3	$2.39M	Buy	21,553 +302	+1%	+$35.1K	0.45%	36
2017 Q2	$2.5M	Buy	+21,251	New	+$2.46M	0.54%	40
2017 Q1	–	Sell	-14,440	Closed	-$1.32M	–	645
2016 Q4	$1.32M	Buy	14,440 +13,258	+1,122%	+$1.23M	0.26%	75
2016 Q3	$115K	Sell	1,182 -655	-36%	-$65.6K	0.02%	236
2016 Q2	$187K	Buy	1,837 +864	+89%	+$86.2K	0.03%	206
2016 Q1	$95.5K	Buy	+973	New	+$89.2K	0.01%	247
2015 Q3	–	Sell	-10,996	Closed	-$905K	–	561
2015 Q2	$882K	Sell	10,996 -6,300	-36%	-$518K	0.09%	101
2015 Q1	$1.3M	Buy	17,296 +8,819	+104%	+$716K	0.14%	81
2014 Q4	$690K	Buy	+8,477	New	+$728K	0.1%	121

Other funds holding PM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Exane Derivatives's PM Position: Q2 2022 in Review

Exane Derivatives reduced its Philip Morris (PM) stake by 43% in Q2 2022, selling an estimated $1.02K and leaving 13 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Exane Derivatives first reported a position in PM in Q4 2014 and has held it in 28 quarters since. The position peaked at $6.45M in Q2 2018. 1,981 funds tracked by Wall St. Rank hold PM as of Q2 2022.

Exane Derivatives held 13 shares of Philip Morris worth $1.28K as of Q2 2022.
Exane Derivatives sold 10 Philip Morris shares in Q2 2022, an estimated $1.02K.
Philip Morris made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #479 holding.
Exane Derivatives first reported a position in Philip Morris in Q4 2014 and has held it in 28 quarters since.
Exane Derivatives's Philip Morris position peaked at $6.45M in Q2 2018.
1,981 funds tracked by Wall St. Rank held Philip Morris as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.